Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

BACKGROUND: Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the release, the volume of myocardial tissue loss, and the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hueb, Whady, Gersh, Bernard J, Rezende, Paulo Cury, Garzillo, Cibele Larrosa, Lima, Eduardo Gomes, Vieira, Ricardo D'Oliveira, Garcia, Rosa Maria Rahmi, Favarato, Desiderio, Segre, Carlos Alexandre W, Pereira, Alexandre Costa, Soares, Paulo Rogério, Ribeiro, Expedito, Lemos, Pedro, Perin, Marco A, Strunz, Célia Cassaro, Dallan, Luis AO, Jatene, Fabio B, Stolf, Noedir AG, Hueb, Alexandre Ciappina, Dias, Ricardo, Gaiotto, Fabio A, da Costa, Leandro Menezes Alves, Oikawa, Fernando Teiichi Costa, de Melo, Rodrigo Morel Vieira, Serrano, Carlos Vicente, de Ávila, Luiz Francisco Rodrigues, Villa, Alexandre Volney, Filho, José Rodrigues Parga, Nomura, César, Ramires, José AF, Filho, Roberto Kalil
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468382/
https://ncbi.nlm.nih.gov/pubmed/22898311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-12-65
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak